Harvest Health (CNSX: HARV, OTCMKTS: HRVSF) has posted their results for Q4 2019. Revenue came in at $37.8M which missed analysts’ estimates of $39.45M Adjusted EBITDA came in -$6.8M which missed estimates of -$3.23M The company posted the following highlights for the Full Fiscal 2019 year: New capital raised during 2019 included short-term debt, unsecured […]
Category: News
Trulieve Posts Q4 2019 Earnings Beat – The Ultimate Value Cannabis Stock?
Trulieve Cannabis Corp (CNSX: TRUL , OTCMKTS: TCNNF) has posted their results for Q4 2019. Revenue came in at $79.7M which beat analysts’ estimates of $79.54M Adjusted EBITDA came in $45.0M which beat estimates of $32.19M Comparing Trulieve’s stock performance to its peers, we see that although the stock price has decline by over 30% […]
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 12th, 2020)
Bottom Line: With much of the global population stuck indoors, we are already seeing indications of spiking consumption and demand for pot, booze and smokes. Historically the stocks in these sectors outperform the market during recessions, will this time be any different? Read more» Bottom Line: European Union Good Manufacturing Practice (EU-GMP) certification audits […]
What Does Aurora Cannabis’ 12-for-1 Reverse Stock Split Mean for You
Aurora Cannabis (TSE:ACB, NYSE:ACB) has announced a 12-to-1 consolidation (otherwise known as a reverse split) of its common shares effective on or around May 11, 2020. This consolidation will see its 1,313,494,990 shares consolidated down to 109,457,915 shares. The stock price will go from $0.74 as we write this to $8.76 per share, but a […]
Bull Market in Vice: Interview with Trulieve CEO Kim Rivers
Grizzle sat down for an exclusive interview with Kim Rivers, the CEO of cannabis market leader Trulieve. Kim confirms if recent rumors of sales spikes across North America are true and takes us through how Trulieve is adapting in a COVID-19 world. Full of unique insights on the company and the cannabis market you won’t […]
Aurora Decreases Potential Stock Issuance to $250M From $350M
We previously reported on Aurora Cannabis’ plans to raise more capital in an at-the-market equity program valued at around $350M. Now we are getting news that in a recent filing with SEDAR, the company has made plans with Cowen & Co and BMO Capital Markets to increase the original $400M program up to $650M, a […]
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 18th, 2020)
Bottom Line: In this edition of The Post Roll, we review all the big earnings this week. What went wrong, what went right and what the numbers mean for the stock prices. Read more» Bottom Line: Grizzle sat down for an exclusive interview with Kim Rivers, the CEO of cannabis market leader Trulieve. Check out […]
Organigram Announces $49M At-The-Market Equity Program
Earlier, we reported on Organigram’s (TSE:OGI, NASDAQ:OGI) Q2 2020 earnings which raised some concerns about the company’s cash position. Now, as we feared and warned investors about earlier, the company has announced today that it is doing a at-the-market equity raise program valued at $49M. In particular, the company is burning through around $46M every […]
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 25th, 2020)
Bottom Line: We warned investors last week that Organigram had a cash problem. Now in a release that should have surprised no one they are issuing stock to continue funding their business. The share count will go up 15% if Organigram uses the program in full. Read more» Bottom Line: Yet another producer cutting prices […]